AI Image
FDA Announces New Nationwide Blood Pressure Medication Recall
Yahoo News Singapore • • general
Key Points:
- Inventia Healthcare has issued a Class II recall for certain lots of chlorthalidone tablets, a medication used to treat high blood pressure, due to failed dissolution specifications which may reduce the drug's effectiveness.
- The recall includes over 13,000 bottles from a specific lot (Batch# RISA24002) of 25 mg chlorthalidone tablets with an expiration date of April 2027.
- A Class II recall indicates that exposure to the affected medication may cause temporary or reversible health issues, but serious problems are unlikely.
- Patients with the recalled medication should not stop taking it without consulting their healthcare provider and should report any adverse symptoms immediately.
- Consumers are advised to check their medication labels carefully and contact their pharmacist if they are unsure whether their chlorthalidone is part of the recall.
